Fig. 2From: Reduction of CTRP9, a novel anti-platelet adipokine, contributes to abnormal platelet activity in diabetic animalsHFD significantly increased plasma insulin concentration (a) and HOMA-IR (b), and reduced plasma CTRP9 concentration (c). N = 15 group. *P < 0.05, **P < 0.01 vs. NDBack to article page